Co-Authors
                                
                                
                                    This is a "connection" page, showing publications co-authored by Giuseppe Lippi and Andrea Horvath.
                                
                                
                                
                                    
                                        
                                                
    
        
        
        
            Connection Strength
            
                
            
            1.299
         
        
        
     
 
    
        
        - 
            Setting minimum clinical performance specifications for tests based on disease prevalence and minimum acceptable positive and negative predictive values: Practical considerations applied to COVID-19 testing. Clin Biochem. 2021 Feb; 88:18-22.
            
            
                Score: 0.229
             
- 
            IFCC Interim Guidelines on Molecular Testing of SARS-CoV-2 Infection. Clin Chem Lab Med. 2020 10 07; 58(12):1993-2000.
            
            
                Score: 0.227
             
- 
            Editorial and Executive Summary: IFCC Interim Guidelines on Clinical Laboratory testing during the COVID-19 Pandemic. Clin Chem Lab Med. 2020 10 07; 58(12):1965-1969.
            
            
                Score: 0.227
             
- 
            Biosafety measures for preventing infection from COVID-19 in clinical laboratories: IFCC Taskforce Recommendations. Clin Chem Lab Med. 2020 06 25; 58(7):1053-1062.
            
            
                Score: 0.222
             
- 
            IFCC interim guidelines on rapid point-of-care antigen testing for SARS-CoV-2 detection in asymptomatic and symptomatic individuals. Clin Chem Lab Med. 2021 08 26; 59(9):1507-1515.
            
            
                Score: 0.059
             
- 
            IFCC Interim Guidelines on Serological Testing of Antibodies against SARS-CoV-2. Clin Chem Lab Med. 2020 10 07; 58(12):2001-2008.
            
            
                Score: 0.057
             
- 
            IFCC Interim Guidelines on Biochemical/Hematological Monitoring of COVID-19 Patients. Clin Chem Lab Med. 2020 10 07; 58(12):2009-2016.
            
            
                Score: 0.057
             
- 
            Staff rostering, split team arrangement, social distancing (physical distancing) and use of personal protective equipment to minimize risk of workplace transmission during the COVID-19 pandemic: A simulation study. Clin Biochem. 2020 Dec; 86:15-22.
            
            
                Score: 0.056
             
- 
            Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence. Clin Chem Lab Med. 2020 06 25; 58(7):1037-1052.
            
            
                Score: 0.056
             
- 
            Operational considerations and challenges of biochemistry laboratories during the COVID-19 outbreak: an IFCC global survey. Clin Chem Lab Med. 2020 08 27; 58(9):1441-1449.
            
            
                Score: 0.055
             
- 
            Laboratory practices to mitigate biohazard risks during the COVID-19 outbreak: an IFCC global survey. Clin Chem Lab Med. 2020 08 27; 58(9):1433-1440.
            
            
                Score: 0.055